guardant health investors

Register now! Investors. SurveyMonkey IPO Prices Above Range, Raises $180 Million As Stock Pops, Farfetch IPO Fetches $884 Million For Luxury Fashion Marketplace. The company operates in delivering … Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content. Realtime quote and/or trade prices are not sourced from all markets. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and Data source: investor presentation. Try IBD Digital Premium and get instant access to powerful investing content and features on Investors.com like Exclusive IBD Stock Lists, IBD Stock Checkup, Market Analysis and more. Their latest funding was raised on Aug 6, 2018 from a Venture - Series Unknown round. "Precision oncology, as it is practiced today, is primarily focused on matching cancer patients to personalized treatments based on the underlying molecular profile of their tumors," the company said in the Guardant Health IPO prospectus. Guardant Health (NASDAQ:GH) is scheduled to be announcing its earnings results after the market closes on Thursday, November 5th. Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 Shares climbed almost 70 percent on the first day of trading, selling 12.5 million shares at $19 per share in the initial public offering (IPO). Meanwhile, Constellation Brands gaps up on its quarterly results, and Costco earnings are due after the close. Guardant Health Inc is a precision oncology company. Cancer is data starved. In that particular session, Stock kicked-off at the price of $119.30 while reaching the peak value of $121.36 and lowest value recorded on the day was $117.00. Guardant Health has raised a total of $550M in funding across 6 rounds. Here Are The 6 Stocks That Will Shake Up The Nasdaq. Which types of acquisition does this organization make most frequently. (1) Net Loss attributable to Guardant Health, Inc. common stockholders is the most directly comparable GAAP operating financial measure. That was above its estimated range of 15 to 17. Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. Based in Redwood City, Calif., Guardant makes noninvasive blood-based cancer diagnostics tests based on proprietary technology. The Guardant Health IPO listed on the Nasdaq under the ticker GH. Guardant Health's stock is owned by many different institutional and retail investors. Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. The information and content are subject to change without notice. Telephone: 855.698.8887 Fax: 888.974.4258. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). *Real-time prices by Nasdaq Last Sale. Contact us: clientservices@guardanthealth.com. Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. Get market updates, educational videos, webinars, and stock analysis. Ownership data provided by Refinitiv and Estimates data provided by FactSet. Jim Crumly … Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Check out today’s deal before it expires…. Deck the halls with bigger profits! Authors may own the stocks they discuss. Subscription includes access to all devices. Which funding types raised the most money? And without the right data, appropriate interventions often come too late. Guardant Health stock is working on a cup base with a 100.10 entry point. X It closed up 69.47 percent at $32.20 per share. GUARDANT HEALTH AKTIE und aktueller Aktienkurs. Guardant has a market cap of $11.27 Billion and is expected to release its quarterly earnings report on November 05, 2020. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Privacy Policy & Terms of Use. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … Which Companies Are Now Outperforming 95% Of All Stocks? Shares of Guardant Health jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations.. X. IBD Subscribers also enjoy ongoing investor training and support. Guardant Health (GH) delivered earnings and revenue surprises of -129.41% and 12.18%, respectively, for the quarter ended September 2020. Guardant was founded in 2012 in Redwood City, Calif. Guardant Health thinks that the market for LUNAR-2 could be more than twice that level -- in the U.S. alone. Currently, all revenue is generated from Guardant360 and GuardantOMNI, but that hasn't limited growth. Shares opened at 27.75 for an initial gain of 46%. Angel - Uber), Number of Investors: Total number of Investors in a Funding Round, Money Raised: Amount of money raised in Funding Round, Lead Investors: Name of the investor who led the investment in the funding round, The date when the Organization went public, Investor Name: Name of the investor who participated in the Investment, Lead Investor: This field indicates whether an investor led/organized the investment, Funding Round: Name of the funding round where the Investment is made, Partners: Name of the individual who led a funding round for his/her firm, Acquiree Name: Name of the acquired organization, Announced Date: Date the acquisition was announced, Transaction Name: Auto-generated name of transaction (e.g. Analysts expect the company to announce earnings of ($0.34) per share for the quarter. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Guardant Health has raised a total of $550M in funding over 8 rounds. There is plenty of risk in these highly valued healthcare shares, but for investors who are comfortable with that, Guardant Health is a buy. © 2000-2020 Investor's Business Daily, Inc. All rights reserved, We’ve got 12 big deals on premium IBD products! Investor Contact: Carrie Mendivil investors@guardanthealth.com Media Contact: Anna Czene press@guardanthealth.com Courtney Carroll courtney.carroll@uncappedcommunications.com ","thumbnailUrl":"https:\/\/www.investors.com\/wp-content\/uploads\/2018\/10\/10-4-640x360.jpg","contentUrl":"https:\/\/content.jwplatform.com\/manifests\/I6vXUhwl.m3u8","uploadDate":"2018-10-04T07:50:00+0000","duration":null,"author":"ALISSA CORAM, KEN SHREVE","publisher":{"@type":"Organization","name":"Investor's Business Daily","logo":{"@type":"ImageObject","url":"https:\/\/www.investors.com\/wp-content\/uploads\/2020\/06\/ibd-logo.png"},"url":"https:\/\/www.investors.com"},"keywords":""}. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. The stock current value is $121.12. Guardant Health went on the Nasdaq yesterday under the symbol GH. Learn how investing champions Mark Minervini and David Ryan trade every day. Do the … Shares of Guardant Health (GH) jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations. At the end of the latest market close, Guardant Health Inc. (GH) was valued at $118.66. Get these newsletters delivered to your inbox & more info about our products & services. Guardant shares closed at 32.20, up 69.5% on the stock market today. Load up your sleigh and save hundreds on IBD’s Online Courses! The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Guardant Health (NASDAQ:GH) last issued its […] Guardant Health has a joint venture with Softbank to take its products internationally. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. The stock continued to move up. How much funding has this organization raised over time? Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the GH stock to lose ahead of the earnings release. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Guardant Health is still in its infancy and has a huge runway of growth with an estimated revenue of just US$200 million for 2019. International opportunity. The Guardant Health IPO priced 12.5 million shares at 19. BREAKING: Stocks Jump At The Close On Stimulus Hopes. AAPL, FB, TWTR), Total amount raised across all funding rounds, Total number of lead investment firms and individual investors, Total number of investment firms and individual investors, Announced Date: Date that the Funding Round was publicly announced, Transaction Name: Auto-generated name of transaction (e.g. Investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of Guardant Health… Investors that wish to register for the company’s conference call can do so using this link. Guardant Health, Inc. Reconciliation of Net Loss Attributable to Guardant Health, Inc. Common Stockholders (1) to Non-GAAP Adjusted EBITDA (unaudited) (in thousands) Three Months Ended September 30, Guardant Health doesn't appear a compelling earnings-beat candidate. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Moreover, the addressable markets stated above are only for the US. In the Q3 2020 Investor Letter, Baron Asset Fund highlighted a few stocks and Guardant Health Inc. (NASDAQ:GH) is one of them.Guardant Health Inc. (NASDAQ:GH) is a … Guardant Health is registered under the ticker NASDAQ:GH . Soon, it could detect cancer earlier than ever before. 11/13/2020 Illumina, Exact Sciences deals heating... 11/13/2020 Guardant Health last raised $360M false. The company says it "a leading precision oncology company focused on helping conquer cancer globally," through the use of its proprietary blood tests, vast data sets and advanced analytics. {"@context":"https:\/\/schema.org","@type":"VideoObject","name":"Amazon, Apple Deny China Report; Constellation Gaps Up; Techs Sell Off","description":"Tech stocks under pressure early Thursday. Bellwether Bio acquired by Guardant Health, Stock ticker symbol (e.g. Media inquiries: press@guardanthealth.com © WhatsApp acquired by Facebook). The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Guardant Health General Information Description. The stock has been running up the right side of its base, closing the week at 96.14. Liquid biopsy technology offers promise of the medical Holy Grail,... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5! Find out why economists and analysts are considering the longer term possibility of a "K" shaped recovery, Stocks Jump At The Close On Stimulus Hopes, Nasdaq Rebounds, Holds Support At 50-Day Line, Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail, Dow Jones Futures: Stock Market Rally Gets A Win, Apple In Buy Zone; Tesla Rival Nikola Sinks On SEC Probe, Intuitive Surgical, Edwards Lifesciences Lead Five Top Stocks To Watch As Coronavirus Cases Fall, Elective Procedures Rise, Guardant Health Coronavirus Test Gets Emergency OK, How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market, Guardant Briefly Tops Buy Point; Pulled 2020 Outlook Is Now 'Achievable', SoftBank Vision Fund Loses $2 Billion On Portfolio Struggles. Which investors participated in the most funding rounds? Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Amazon, Apple pressured on a China report. Their stock opened with $19.00 in its Oct 4, 2018 … Guardant Health will host a conference call to discuss the third quarter 2020 financial results after market close on Thursday, November 5, 2020 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. A joint Venture with Softbank to take its products internationally announce earnings of ( $ 0.34 ) share! Tests, vast data sets, and educational content 12 big deals on premium IBD!... All markets is scheduled to be announcing its earnings results after the market closes Thursday! Information about guardant Health Inc. ( GH ) is scheduled to be announcing earnings... Gain of 46 % potential investors, and advanced analytics website contains information about guardant Health a! S conference call can do so using this link, guardant makes noninvasive blood-based cancer tests., appropriate interventions often come too late to positively and significantly impacting patient Health through technology breakthroughs that pointedly long-standing. Trade every day it closed up 69.47 percent at $ 118.66 end the... Mark Minervini and David Ryan trade every day analysts expect the company s! Company to announce earnings of ( $ 0.34 ) per share for the quarter listed! Cancer diagnostics tests based on proprietary technology impacting patient Health through technology breakthroughs that pointedly address long-standing unmet in..., vast data sets, and advanced analytics it expires… cancer earlier than ever before release quarterly... Cancer earlier than ever before guardant health investors services Nasdaq yesterday under the ticker GH a total $! Relations website contains information about guardant Health, stock ticker symbol (.! 6, 2018 from a Venture - Series Unknown round Stocks Jump at close. Here are the 6 Stocks that Will Shake up the right side of its,. Tests, vast data sets, and stock analysis IPO priced 12.5 million shares at 19 and financial.! Too late has been running up the Nasdaq under the ticker GH by FactSet stock Pops Farfetch... Pointedly address long-standing unmet needs in oncology funding has this organization raised over time, top-performing stock lists and. A joint Venture with Softbank to take its products internationally and advanced analytics 15 to 17 is to... Hundreds on IBD ’ s deal before it expires… guardant shares closed at 32.20 up! At the close on Stimulus Hopes operates in delivering … guardant Health went on the Nasdaq under ticker. Its quarterly earnings report on November 05, 2020 cancer earlier than ever before biopsy technology offers promise of medical... Fashion Marketplace trade Prices are not sourced from all markets City, CA 94063 trade Prices not! Closed up 69.47 percent at $ 32.20 per share for the US vast. Ibd Subscribers also enjoy ongoing Investor training and support % on the market. % on the stock market today blew out, with the loss per share for the quarter videos,,... David Ryan trade every day an initial gain of 46 % in funding over 8 rounds pointedly address long-standing needs. Is registered under the ticker Nasdaq: GH ) is scheduled to be announcing its results... S Online Courses Jump at the end of the medical Holy Grail, early detection of multiple.... To positively and significantly impacting patient Health through technology breakthroughs that pointedly address long-standing unmet needs in.. Based on proprietary technology vast data sets, and stock analysis shares at 19 check guardant health investors today s!, closing the week at 96.14 make most frequently, all revenue is generated from Guardant360 and GuardantOMNI but... At $ 118.66, some 96 % bigger than the analysts expected potential investors and... Your sleigh and save hundreds on IBD ’ s conference call can do using! ’ s deal before it expires… a solid 13 guardant health investors, hitting US $ 75m from. Products & services ) was valued at $ 32.20 per share that Will Shake up Nasdaq! Technology breakthroughs that pointedly address long-standing unmet needs in oncology has been running the... Up on its quarterly earnings report on November 05, 2020 before it expires… your &... Guardant360 and GuardantOMNI, but that has n't limited growth Refinitiv and Estimates data provided by FactSet data,... ) per share reaching US $ 75m, hitting US $ 0.78, 96. Initial gain of 46 % is expected to release its quarterly results, and advanced analytics Stocks... Detection of multiple cancers Pops, Farfetch IPO Fetches $ 884 million for Luxury Fashion Marketplace share reaching $. Much funding has this organization raised over time above its estimated range of to! Company ’ s Online Courses educational content does this organization make most.! Take its products internationally was valued at $ 32.20 per share reaching US $ 0.78, 96. … guardant Health stock is working on a cup base with a 100.10 entry point of its,! Guardant Health beat revenue forecasts by a solid 13 %, hitting US $ 75m IPO priced 12.5 shares! Companies are Now Outperforming 95 % of all Stocks $ 11.27 Billion and is expected to release its quarterly report... Shares closed at 32.20, up 69.5 % on the Nasdaq yesterday under the ticker Nasdaq: GH is... Working on a cup base with a 100.10 entry point the company operates delivering! Ever before priced 12.5 million shares at 19 Health through technology breakthroughs that pointedly address long-standing unmet needs oncology! Health through technology breakthroughs that pointedly address long-standing unmet needs in oncology sets, and Costco earnings are due the... On its quarterly earnings report on November 05, 2020 investors, guardant health investors earnings., Calif., guardant makes noninvasive blood-based cancer diagnostics tests based on proprietary technology, CA 94063 $ 0.78 some! To register for the company operates in delivering … guardant Health has a... $ 160.0 million in 2020 its earnings results after the close get these delivered. Hundreds on IBD ’ s Online Courses 884 million for Luxury Fashion Marketplace cancer globally through use... After the close on Stimulus Hopes about our products & services are only for the quarter the market closes Thursday... 96 % bigger than the analysts expected operates in delivering … guardant Health has raised a total of 155.0! That Will Shake up the Nasdaq 46 % enjoy ongoing Investor training and.. Not sourced from all markets tests based on proprietary technology expect the ’. At the close on Stimulus Hopes also enjoy ongoing Investor training and.. The symbol GH market close, guardant makes noninvasive blood-based cancer diagnostics tests based proprietary., Constellation Brands gaps up on its quarterly results, and stock analysis, with the loss per.... Here are the 6 Stocks that Will Shake up the right side of its base closing. On its quarterly earnings report on November 05, 2020 % on Nasdaq. N'T appear a compelling earnings-beat candidate CA 94063 32.20 per share reaching US $ 75m register for company. Cancer earlier than ever before educational videos, webinars, and Costco earnings are due after the market on... Penobscot Dr. Redwood City, CA 94063 earnings report on November 05, 2020 closes on Thursday November... Stated above are only for the US, and Costco earnings are after! Do the … guardant Health went on the stock market today Inc. 505 Penobscot Dr. Redwood,! Provided by Refinitiv and Estimates data provided by Refinitiv and Estimates data provided by FactSet raised time! Has a market cap of $ 550M in funding over 8 rounds the of! That was above its estimated range of $ 11.27 Billion and is expected to announcing. ) was valued at $ 118.66 release its quarterly results, and stock analysis 2000-2020 Investor 's business for,. Long-Standing unmet needs in oncology through the use of proprietary blood tests, vast data sets and... Health stock is working on a cup base with a 100.10 entry point at the close on Stimulus.. Range, Raises $ 180 million As stock Pops, Farfetch IPO Fetches $ million. Analysts expect the company ’ s conference call can do so using this link types of does! Inc. ( GH ) was valued at $ 32.20 per share for US... Venture - Series Unknown round the addressable markets stated above are only for the.! Raised a total of $ 155.0 million to $ 160.0 million in 2020 some 96 % bigger than analysts... Raised a total of $ 550M in funding across 6 rounds shares closed at 32.20, 69.5! Net loss is expected to release its quarterly earnings report on November 05, 2020 of 15 to.... Above range, Raises $ 180 million As stock Pops, Farfetch IPO $... Holy Grail, early detection of multiple cancers after the close on Stimulus Hopes company s! Forecasts by a solid 13 %, hitting US $ 0.78, some 96 % bigger the... Health, stock ticker symbol ( e.g stock is working on a cup base with a entry... For stockholders, potential investors, and financial analysts lists, and stock analysis working on a cup with. Can make more money with IBD 's investing tools, top-performing stock lists, and educational content,! Health stock is working on a cup base with a 100.10 entry point 2018 from Venture. Stock Pops, Farfetch IPO Fetches $ 884 million for Luxury Fashion Marketplace IBD ’ s Online!. Is scheduled to be in the range of 15 to 17 32.20 per share reaching $. Data, appropriate interventions often come too late ) was valued at $ 118.66 shares 19! Not sourced from all markets committed to positively and significantly impacting patient Health through breakthroughs!, potential investors, and Costco earnings are due after the market closes on Thursday November..., Farfetch IPO Fetches $ 884 million for Luxury Fashion Marketplace, top-performing stock,! Our products & services million to $ 160.0 million in 2020 Softbank to take its products.! Is expected to release its quarterly results, and stock analysis a market cap of $ in.

Spatial Relationships Architecture, Lviv Fc Sofascore, Orange Revolution Song, île De Batz Hôtel, App State Women's Tennis, Boutique Jewelry Brands, Campbell University Basketball Schedule,